GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (XBUL:22UA) » Definitions » Long-Term Debt

BioNTech SE (XBUL:22UA) Long-Term Debt : лв428 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is BioNTech SE Long-Term Debt?

BioNTech SE's Long-Term Debt for the quarter that ended in Sep. 2024 was лв428 Mil.

BioNTech SE's quarterly Long-Term Debt increased from Mar. 2024 (лв416 Mil) to Jun. 2024 (лв441 Mil) but then declined from Jun. 2024 (лв441 Mil) to Sep. 2024 (лв428 Mil).

BioNTech SE's annual Long-Term Debt declined from Dec. 2021 (лв362 Mil) to Dec. 2022 (лв349 Mil) but then increased from Dec. 2022 (лв349 Mil) to Dec. 2023 (лв389 Mil).

BioNTech SE Long-Term Debt Historical Data

The historical data trend for BioNTech SE's Long-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioNTech SE Long-Term Debt Chart

BioNTech SE Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Debt
Get a 7-Day Free Trial - 525.23 362.39 348.85 389.29

BioNTech SE Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Long-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 322.94 389.29 416.46 441.20 427.94

BioNTech SE  (XBUL:22UA) Long-Term Debt Explanation

Long-Term Debt is the sum of the carrying values as of the balance sheet date of all long-term debt, which is debt initially having maturities due after one year or beyond the operating cycle, if longer, but excluding the portions thereof scheduled to be repaid within one year or the normal operating cycle, if longer. Long-Term Debt includes notes payable, bonds payable, mortgage loans, convertible debt, subordinated debt and other types of long term debt.

BioNTech SE Long-Term Debt Related Terms

Thank you for viewing the detailed overview of BioNTech SE's Long-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

BioNTech SE Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » BioNTech SE (XBUL:22UA) » Definitions » Long-Term Debt
Comparable Companies
BGNE ALNY MRNA BMRN RPRX LEGN INCY UTHR SRPT TECH OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 HKSE:02269 XBRU:ARGX SZSE:300122 OCSE:GMAB
Traded in Other Exchanges
BNTX:USA BNTX:Mexico 0A3M:UK 22UA:Germany B1NT34:Brazil BNTX:Austria
Address
An der Goldgrube 12, Mainz, RP, DEU, D-55131
Website
https://www.biontech.de
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including covid. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies; cell therapies; bispecific antibodies; and antibody-drug conjugates, or ADCs. BioNTech is partnered with several large pharmaceutical companies, including Roche, Eli Lilly, Pfizer, Sanofi, and Genmab. Covid vaccine Comirnaty is its first commercialized product.

BioNTech SE Headlines

No Headlines